BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17599831)

  • 1. CD44 regulates cell migration in human colon cancer cells via Lyn kinase and AKT phosphorylation.
    Subramaniam V; Vincent IR; Gardner H; Chan E; Dhamko H; Jothy S
    Exp Mol Pathol; 2007 Oct; 83(2):207-15. PubMed ID: 17599831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation and dephosphorylation of cofilin: modulation by CD44 variant isoform in human colon cancer cells.
    Subramaniam V; Vincent IR; Jothy S
    Exp Mol Pathol; 2005 Dec; 79(3):187-93. PubMed ID: 16229833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. shRNA against CD44 inhibits cell proliferation, invasion and migration, and promotes apoptosis of colon carcinoma cells.
    Park YS; Huh JW; Lee JH; Kim HR
    Oncol Rep; 2012 Feb; 27(2):339-46. PubMed ID: 22076607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor-2 stimulates directed migration of periodontal ligament cells via PI3K/AKT signaling and CD44/hyaluronan interaction.
    Shimabukuro Y; Terashima H; Takedachi M; Maeda K; Nakamura T; Sawada K; Kobashi M; Awata T; Oohara H; Kawahara T; Iwayama T; Hashikawa T; Yanagita M; Yamada S; Murakami S
    J Cell Physiol; 2011 Mar; 226(3):809-21. PubMed ID: 20857427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A CD44 survival pathway triggers chemoresistance via lyn kinase and phosphoinositide 3-kinase/Akt in colon carcinoma cells.
    Bates RC; Edwards NS; Burns GF; Fisher DE
    Cancer Res; 2001 Jul; 61(13):5275-83. PubMed ID: 11431370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine kinase 1 plays a role in the upregulation of CD44 expression through extracellular signal-regulated kinase signaling in human colon cancer cells.
    Kawahara S; Otsuji Y; Nakamura M; Murakami M; Murate T; Matsunaga T; Kanoh H; Seishima M; Banno Y; Hara A
    Anticancer Drugs; 2013 Jun; 24(5):473-83. PubMed ID: 23426175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rho-kinase inhibitor upregulates migration by altering focal adhesion formation via the Akt pathway in colon cancer cells.
    Adachi S; Yasuda I; Nakashima M; Yamauchi T; Yoshioka T; Okano Y; Moriwaki H; Kozawa O
    Eur J Pharmacol; 2011 Jan; 650(1):145-50. PubMed ID: 20959118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel signaling pathway associated with Lyn, PI 3-kinase and Akt supports the proliferation of myeloma cells.
    Iqbal MS; Tsuyama N; Obata M; Ishikawa H
    Biochem Biophys Res Commun; 2010 Feb; 392(3):415-20. PubMed ID: 20079716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble CD44 secretion contributes to the acquisition of aggressive tumor phenotype in human colon cancer cells.
    Subramaniam V; Gardner H; Jothy S
    Exp Mol Pathol; 2007 Dec; 83(3):341-6. PubMed ID: 17945213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of human colon cancer tumors in nude mice by siRNA CD44 gene therapy.
    Subramaniam V; Vincent IR; Gilakjan M; Jothy S
    Exp Mol Pathol; 2007 Dec; 83(3):332-40. PubMed ID: 17945212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44 promotes resistance to apoptosis in human colon cancer cells.
    Lakshman M; Subramaniam V; Rubenthiran U; Jothy S
    Exp Mol Pathol; 2004 Aug; 77(1):18-25. PubMed ID: 15215046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pro-apoptotic protein Prostate Apoptosis Response Protein-4 (Par-4) can be activated in colon cancer cells by treatment with Src inhibitor and 5-FU.
    Kline CL; Irby RB
    Apoptosis; 2011 Dec; 16(12):1285-94. PubMed ID: 21910008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of 3-phosphoinositide-dependent protein kinase-1 levels inhibits migration and experimental metastasis of human breast cancer cells.
    Liu Y; Wang J; Wu M; Wan W; Sun R; Yang D; Sun X; Ma D; Ying G; Zhang N
    Mol Cancer Res; 2009 Jun; 7(6):944-54. PubMed ID: 19531564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migration.
    Ravid D; Chuderland D; Landsman L; Lavie Y; Reich R; Liscovitch M
    Exp Cell Res; 2008 Sep; 314(15):2762-73. PubMed ID: 18598695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity.
    Lue H; Thiele M; Franz J; Dahl E; Speckgens S; Leng L; Fingerle-Rowson G; Bucala R; Lüscher B; Bernhagen J
    Oncogene; 2007 Aug; 26(35):5046-59. PubMed ID: 17310986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTP1B contributes to the oncogenic properties of colon cancer cells through Src activation.
    Zhu S; Bjorge JD; Fujita DJ
    Cancer Res; 2007 Nov; 67(21):10129-37. PubMed ID: 17974954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen and progestin regulate metastasis through the PI3K/AKT pathway in human ovarian cancer.
    Hua K; Feng W; Cao Q; Zhou X; Lu X; Feng Y
    Int J Oncol; 2008 Nov; 33(5):959-67. PubMed ID: 18949358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44 variant isoforms promote metastasis formation by a tumor cell-matrix cross-talk that supports adhesion and apoptosis resistance.
    Klingbeil P; Marhaba R; Jung T; Kirmse R; Ludwig T; Zöller M
    Mol Cancer Res; 2009 Feb; 7(2):168-79. PubMed ID: 19208744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Netrin-1 increases proliferation and migration of renal proximal tubular epithelial cells via the UNC5B receptor.
    Wang W; Reeves WB; Ramesh G
    Am J Physiol Renal Physiol; 2009 Apr; 296(4):F723-9. PubMed ID: 19211685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transactivation of Src, PDGF receptor, and Akt is involved in IL-1beta-induced ICAM-1 expression in A549 cells.
    Lin CC; Lee CW; Chu TH; Cheng CY; Luo SF; Hsiao LD; Yang CM
    J Cell Physiol; 2007 Jun; 211(3):771-80. PubMed ID: 17299794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.